International Hellenic University
Παράγοντες διαμόρφωσης της ψυχικής νοσηρότητας από την επίδραση του χρόνιου νευροπαθητικού πόνου μέσω φυσικοθεραπευτικών παρεμβάσεων γνωστικού χαρακτήρα: μία πολυδιάστατη μελέτη
Abstract
dc:descriptionBackground: Chronic Neurogenic Low Back Pain (CNLBP) poses a significant challenge in healthcare due to its complex pathophysiology. Existing therapeutic approaches have proven inadequate, offering only limited relief from symptoms. Cognitive Functional Therapy (CFT), a multidimensional, patient-centered intervention representing a comprehensive therapeutic model, targets the management of chronic low back pain, by addressing all its facets. Purpose: The present thesis includes a multidimensional experimental study in two phases: Phase A, a cross-sectional analysis, aiming to investigate the correlations between pain intensity, functional disability, kinesiophobia, anxiety, depressive mood and quality of life in patients with CNLBP, and subsequently, Phase B, a randomized controlled trial, aiming to compare the effect of two interventions—CFT and a core-strengthening program—on the physical aspect of the condition (pain intensity and functional disability) and on the psychosocial characteristics [quality of life, kinesiophobia, Generalized Anxiety Disorder (GAD), depressive mood]. Methods: In Phase A, 70 adults with CNLBP participated [radiculopathy with duration≥3 months, DN4>4, positive Lasègue test, Short-form McGill Pain Questionnaire (SF-MPQ)>0]. The exclusion criteria included severe hypertension, BMI>45 kg/m², active rheumatoid, history of neuromuscular disorders, active malignancy, neurological or psychiatric disorders (DSM-V), pregnancy, involvement in legal health issues, planned surgical intervention, other pain interfering with assessment, lack of full consent or participation in other ongoing studies. The analysis included normality check (Shapiro-Wilk), descriptive statistics (Μ±SD), corellations using Pearson r, and a two stage linear regression (screening p≤0.20, stepwise, VIF<5, α=0.05) among SF-MPQ, RMDQ, FABQ-PA/W, GAD-7, PHQ-9 and WHOQOL-BREF. In phase B, 52 of the cross-sectional’s analysis participants were randomly allocated in two groups: Group A, CFT and Group B, Core strengthening program. The treatments had a four month duration and there were four evaluations points [Baseline (T1), in the middle (T2), at the end of the treatment (T3) and follow-up after four months (T4)]. The parameters remained the same with the cross-sectional analysis (SF-MPQ, RMDQ, FABQ-PAW, GAD-7, PHQ-9, WHOQOL-BREF). The effectiveness of each protocol were assessed with repeated measures and two-way mixed (time, time × Group) ANOVA with Bonferroni post-hoc. T1-T3 presented full cases analysis, while T4 missing data (26,9%) were analyzed with Intention-to-treatment (n=20). The statistical analysis were conducted in SPSS v.25 with a p<0.05 level of significance. Results: In phase A (n=70), the correlation analysis showed positive statistically significant correlations between SF-MPQ and RMDQ (r=0.68, p<0.001), FABQ and RMDQ (r=0.52, p<0.001), GAD-7 and PHQ-9 (r=0.73, p<0.001) and negative correlations between WHOQOL-BREF and all the clinical parameters (r=-0.45 to -0.71, p<0.01). The final regression model [F(3,48)=17.975, SE=4.044, R²=0.450, Αdjusted R²=0.425, p<0,001] presents as significant important predictors of RMDQ: SF-MPQ (Β=1.951, β=0.373, p=0.001), FABQ-PA (Β=0.308, β=0.245, p=0.015) and WHOQOL-BREF Q1 (Β=-1.813, β=-0.275, p=0.008).In phase B (n=52), the repeated measures ANOVA showed significant time effects in all the parameters: SF-MPQ [F93.150)=52.98, p<0.001], RMDQ [F(3.96)=20.46, p<0.001], FABQ-PA [F(3.96)=11.46, p<0.001], FABQ-Q [F(2.42)=18.99, p<0.001], GAD-7 [F(2.124, 67.97)=14.47, p<0.001], PHQ-9 [F(2.058,65.86)=25.54, p<0.001] and WHOQOL-BREF [F(2.10, 52.44)=10.72, p<0.001]. Significant time×Group effects were noted in SF-MPQ [F(3,150)=16.239, p<0.001], RMDQ [F(3.96)=6.05, p=0.001], FABQ-PA [F(3.96)=10.34, p<0.001], FABQ-W [F(2.42)=4.89, p=0.012], PHQ-9 [F(2.058,65.86)=3.38, p=0.020] and WHOQOL-BREF [F(2.10,52.44)=3.32, p=0.042, η²p=0.12], apart from GAD-7 [F(2.124,67.970)=0.252, p=0.791, η2p=0.008]. The post-hoc Bonferroni comparisons showed that CFT presented superior results in SF-MPQ (T1–T2 p<0.001; T1–T3 p<0.001; T1–T4 p=0.178; T2–T3 p=1.000; T2–T4 p=0.324; T3–T4 p=0.201), RMDQ (T1–T2 p=0.012; T1–T3 p=0.010; T1–T4 p=0.013; T2–T3 p=1.000; T2–T4 p=1.000; T3–T4 p=1.000), FABQ-PA (T1–T2 p<0.001; T1–T3 p<0.001; T1–T4 p<0.001; T2–T3 p=0.092; T2–T4 p=0.034; T3–T4 p=1.000), FABQ-W (T1–T2 p<0.001; T1–T3 p<0.001; T2–T3 p=0.002), PHQ-9 (T1–T2 p=0.043; T1–T3 p=0.021; T1–T4 p=0.007; T2–T3 p=1.000; T2–T4 p=0.657; T3–T4 p=1.000) and WHOQOL-BREF (T1–T2 p=0,008; T1–T3 p<0,001; T1–T4 p<0,001; T2–T3 p=0,422; T2–T4 p=0,032; T3–T4 p=1,000) at T3-T4. Conclusion: CFT showed higher results in all the parameters of the study, apart from GAD, in comparison with the results of the core strengthening program in patients with CNLBP.
Degree
thesis:*- Grantor dc:publisher
- International Hellenic University
- Year dc:date
- 2026
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Trevlaki, Evgenia
- Τρευλάκη, Ευγενία
Subjects
dc:subject × 24- Γνωστική λειτουργική θεραπεία
- Χρόνιος πόνος
- Οσφυαλγία
- Νευροπαθητικός πόνος
- Ενδυνάμωση κορμού
- Cognitive functional therapy
- Chronic pain
- Low back pain
- Neuropathic pain
- Core strengthening
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, γενικά
- Πρωτοβάθμια φροντίδα υγείας
- Κλινική Ιατρική
- Κλινική νευρολογία
- Ολιστική, Συμπληρωματική και Εναλλακτική ιατρική
- Health Sciences
- Medical and Health Sciences
- Health sciences, general
- Primary Health Care
- Clinical Medicine
- Clinical Neurology
- Integrative, Complementary and Alternative Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/61412